Clinical Trial Update: Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the efficacy and safety of Meteospasmyl for irritable bowel syndrome, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Meteospasmyl

Snippet

Sponsor: Laboratoires Mayoly Spindler | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: COMPLETED